A detailed history of Taylor Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Taylor Financial Group, Inc. holds 1,399 shares of ABBV stock, worth $240,250. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,399
Previous 1,399 -0.0%
Holding current value
$240,250
Previous $240 Million 15.14%
% of portfolio
0.19%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $154 - $180
-1 Reduced 0.07%
1,399 $240 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $14,383 - $16,389
-90 Reduced 6.04%
1,400 $255 Million
Q4 2023

Sep 17, 2024

BUY
$137.6 - $154.97 $12,521 - $14,102
91 Added 6.5%
1,490 $231 Million
Q4 2023

Feb 16, 2024

BUY
$137.6 - $154.97 $205,024 - $230,905
1,490 New
1,490 $231 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Taylor Financial Group, Inc. Portfolio

Follow Taylor Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor Financial Group, Inc. with notifications on news.